What BridgeBio Oncology Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 7 | 21 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 9,038 | 4,653,894 |
| Disposed | 2,969 | 4,536,335 |
| Net activity | +6,069 | +117,559 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cobo Marc | Principal Accounting Officer | Oct 21 | Withheld — tax / exercise cost · F | −203 | $2.68 | −$544 | 13,812 |
| Beltran Pedro | President and CEO | Oct 01 | Withheld — tax / exercise cost · F | −1,047 | $3.94 | −$4.13K | 43,529 |
| Elmelech Idan | COO & Principal Financial Ofcr | Oct 01 | Withheld — tax / exercise cost · F | −343 | $3.94 | −$1.35K | 14,152 |
| Cobo Marc | Principal Accounting Officer | Oct 01 | Withheld — tax / exercise cost · F | −126 | $3.94 | −$496 | 14,015 |
| Ben Yong | Chief Med & Dev Officer | Oct 01 | Withheld — tax / exercise cost · F | −1,047 | $3.94 | −$4.13K | 43,529 |
| Cobo Marc | Principal Accounting Officer | Sep 10 | Withheld — tax / exercise cost · F | −203 | $5.52 | −$1.12K | 14,141 |
| Cobo Marc | Principal Accounting Officer | Sep 10 | Grant / award · A | +9,038 | — | — | 14,344 |
| Beltran Pedro | President and CEO | Jul 01 | Withheld — tax / exercise cost · F | −1,047 | $7.80 | −$8.17K | 44,576 |
| Cobo Marc | Principal Accounting Officer | Jul 01 | Withheld — tax / exercise cost · F | −125 | $7.80 | −$975 | 5,306 |
| Chen Bihua | Director | Jul 01 | Other Transaction · J | +130,865 | — | — | 6,083,221 |
| Chen Bihua | Director | Jul 01 | Other Transaction · J | +1,704,862 | — | — | 5,010,332 |
| Chen Bihua | Director | Jul 01 | Other Transaction · J | +2,692,459 | — | — | 4,879,995 |
| Chen Bihua | Director | Jul 01 | Other Transaction · J | −4,528,186 | — | — | 0 |
| Elmelech Idan | COO & Principal Financial Ofcr | Jul 01 | Withheld — tax / exercise cost · F | −343 | $7.80 | −$2.68K | 14,495 |
| Ben Yong | Chief Med & Dev Officer | Jul 01 | Withheld — tax / exercise cost · F | −1,047 | $7.80 | −$8.17K | 44,576 |
| Mehra Uneek | Insider | Apr 01 | Withheld — tax / exercise cost · F | −524 | $9.03 | −$4.73K | 22,806 |
| Beltran Pedro | President and CEO | Apr 01 | Withheld — tax / exercise cost · F | −1,047 | $9.03 | −$9.45K | 45,623 |
| Ben Yong | Chief Med & Dev Officer | Apr 01 | Withheld — tax / exercise cost · F | −1,047 | $9.03 | −$9.45K | 45,623 |
| Beltran Pedro | Chief Scientific Officer | Mar 10 | Grant / award · A | +46,670 | — | — | 46,670 |
| Mehra Uneek | Chief Financial Officer | Mar 10 | Grant / award · A | +23,330 | — | — | 23,330 |
Loading...
